Standout Papers

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype ... 2011 2026 2016 2021 661
  1. Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update (2013)
    Stuart A. Scott, Katrin Sangkuhl et al. Clinical Pharmacology & Therapeutics
  2. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors (2015)
    J K Hicks, Katrin Sangkuhl et al. Clinical Pharmacology & Therapeutics
  3. Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing (2011)
    J. A. Johnson, Li Gong et al. Clinical Pharmacology & Therapeutics
  4. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics‐Guided Warfarin Dosing: 2017 Update (2017)
    JA Johnson, Li Gong et al. Clinical Pharmacology & Therapeutics
  5. Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group (2019)
    Kelly E. Caudle, Katrin Sangkuhl et al. Clinical and Translational Science
  6. Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC) (2016)
    Kelly E. Caudle, Henry M. Dunnenberger et al. Genetics in Medicine
  7. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing (2020)
    John J. Lima, Cameron D. Thomas et al. Clinical Pharmacology & Therapeutics
  8. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants (2023)
    Chad Bousman, James M. Stevenson et al. Clinical Pharmacology & Therapeutics

Immediate Impact

2 by Nobel laureates 21 from Science/Nature 61 standout
Sub-graph 1 of 20

Citing Papers

Refining the impact of genetic evidence on clinical success
2024 StandoutNature
Transcription regulation by long non-coding RNAs: mechanisms and disease relevance
2024 Standout
1 intermediate paper

Works of Stuart A. Scott being referenced

Haploinsufficiency of the basic helix–loop–helix transcription factorHAND2causes congenital heart defects
2020
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
2013 Standout

Author Peers

Author Last Decade Papers Cites
Stuart A. Scott 4013 1345 1632 1613 136 8.0k
Katrin Sangkuhl 4183 1084 2066 1551 69 8.1k
Michelle Whirl‐Carrillo 5302 1806 2357 2427 104 9.5k
Zeruesenay Desta 3838 2494 1419 904 165 8.4k
Larisa H. Cavallari 2995 683 652 996 193 5.1k
Ron H. N. van Schaik 2691 747 2037 2069 239 8.9k
Julia Kirchheiner 3528 434 1174 1111 104 6.3k
Todd C. Skaar 2901 3119 2273 852 209 8.2k
Andrea Gaedigk 8587 1733 2633 3455 235 13.2k
Bob Wilffert 1648 379 1636 777 232 5.5k
Ute I. Schwarz 1939 284 718 1174 86 5.5k

All Works

Loading papers...

Rankless by CCL
2026